Predicting the public health benefit of vaccinating cattle against Escherichia coli O157

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 40, 2013, Pages 16265-16270

  Matthews, Louise ^a   Reeve, Richard ^a,b   Gally, David L ^c   Low, J Chris ^d   Woolhouse, Mark E J ^e   McAteer, Sean P ^c   Locking, Mary E ^f   Chase Topping, Margo E ^e   Haydon, Daniel T ^a   Allison, Lesley J ^g   Hanson, Mary F ^g   Gunn, George J ^h   Reid, Stuart W J ⁱ  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f HEALTH PROTECTION SCOTLAND   (United Kingdom)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^h SCOTTISH AGRICULTURAL COLLEGE   (United Kingdom)

ⁱ ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

80 20 rule; Cross species transmission; One health; Zoonoses

Indexed keywords

ESCHERICHIA COLI VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ESCHERICHIA COLI O157; GASTROINTESTINAL DISEASE; GENETIC MARKER; HUMAN; INFECTION RISK; LIVESTOCK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; RISK MANAGEMENT; VACCINATION; ZOONOSIS;

80-20 RULE; CROSS-SPECIES TRANSMISSION; ONE HEALTH; ZOONOSES;

ANIMALS; BACTERIAL SHEDDING; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; HUMANS; MASS VACCINATION; MODELS, IMMUNOLOGICAL; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; RISK ASSESSMENT; SCOTLAND; SHIGA TOXIN 2; ZOONOSES;

EID: 84885047100     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304978110     Document Type: Article

References (48)

1. Pennington H (2010) Escherichia coli O157. Lancet 376(9750):1428-1435.
2. Scharff RL (2012) Economic burden from health losses due to foodborne illness in the United States. J Food Prot 75(1):123-131.
3. Stevens MP, van Diemen PM, Dziva F, Jones PW, Wallis TS (2002) Options for the control of enterohaemorrhagic Escherichia coli in ruminants. Microbiology 148(Pt 12): 3767-3778.
4. Thomson DU, et al. (2009) Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle. Foodborne Pathog Dis 6(7):871-877.
5. Fox JT, et al. (2009) Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157. Foodborne Pathog Dis 6(7):893-899.
6. Varela NP, Dick P, Wilson J (2013) Assessing the existing information on the efficacy of bovine vaccination against Escherichia coli O157:H7-a systematic review and metaanalysis. Zoonoses Public Health 60(4):253-268.
7. Snedeker KG, Campbell M, Sargeant JM (2012) A systematic review of vaccinations to reduce the shedding of Escherichia coli O157 in the faeces of domestic ruminants. Zoonoses Public Health 59(2):126-138.
8. McNeilly TN, et al. (2010) Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. Vaccine 28(5):1422-1428.
9. US Government Accountability Office (2012) Preslaughter Interventions Could Reduce E. coli in Cattle (US Government Accountability Office, Washington DC).
10. Narrod C, Zinsstag J, Tiongco M (2012) A one health framework for estimating the economic costs of zoonotic diseases on society. EcoHealth 9(2):150-162.
11. Zinsstag J, Schelling E, Wyss K, Mahamat MB (2005) Potential of cooperation between human and animal health to strengthen health systems. Lancet 366(9503):2142-2145.
12. Ayles, A. (2012) Cattle vaccine in Canada could have prevented massive beef recall. Available at www.foodbeat.com/food-news/cattle-vaccine-in-canada- could-haveprevented-massive-beef-recall/. Accessed October 16, 2012.
13. Health Protection Agency (2010) Review of the Major Outbreak of E. coli O157 in Surrey, 2009. Report of the Independent Investigation Committee (Health Protection Agency, London).
14. Zinsstag J, et al. (2007) Human benefits of animal interventions for zoonosis control. Emerg Infect Dis 13(4):527-531.
15. Bonfoh B, et al. (2012) Representative seroprevalences of brucellosis in humans and livestock in Kyrgyzstan. EcoHealth 9(2):132-138.
16. Roth F, et al. (2003) Human health benefits from livestock vaccination for brucellosis: Case study. Bull World Health Organ 81(12):867-876.
17. Zinsstag J, et al. (2009) Transmission dynamics and economics of rabies control in dogs and humans in an African city. Proc Natl Acad Sci USA 106(35):14996-15001.
18. Lloyd-Smith JO, et al. (2009) Epidemic dynamics at the human-animal interface. Science 326(5958):1362-1367.
19. Besser TE, et al. (2007) Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans. Appl Environ Microbiol 73(3):671-679.
20. Bono JL, et al. (2012) Phylogeny of Shiga toxin-producing Escherichia coli O157 isolated from cattle and clinically ill humans. Mol Biol Evol 29(8):2047-2062.
21. Franz E, et al. (2012) Genetic features differentiating bovine, food, and human isolates of shiga toxin-producing Escherichia coli O157 in The Netherlands. J Clin Microbiol 50(3):772-780.
22. Persson S, Olsen KEP, Ethelberg S, Scheutz F (2007) Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45(6):2020-2024.
23. Jelacic JK, et al. (2003) Shiga toxin-producing Escherichia coli in Montana: Bacterial genotypes and clinical profiles. J Infect Dis 188(5):719-729.
24. Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79(3):1329-1337.
25. Gobert AP, et al. (2007) Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J Immunol 178(12):8168-8174.
26. Robinson CM, Sinclair JF, Smith MJ, O'Brien AD (2006) Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci USA 103(25):9667-9672.
27. Steinberg KM, Levin BR (2007) Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage. Proc Biol Sci 274(1621):1921-1929.
28. Chase-Topping ME, Gally D, Low C, Matthews L, Woolhouse MEJ (2008) Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nat Rev Microbiol 6(12):904-912.
29. Chase-Topping ME, et al. (2007) Risk factors for the presence of high-level shedders of Escherichia coli O157 on Scottish farms. J Clin Microbiol 45(5):1594-1603.
30. Stanford K, Agopsowicz CA, McAllister TA (2012) Genetic diversity and antimicrobial resistance among isolates of Escherichia coli O157: H7 from feces and hides of supershedders and low-shedding pen-mates in two commercial beef feedlots. BMC Vet Res 8:178.
31. Robinson SE, Brown PE, Wright EJ, Hart CA, French NP (2009) Quantifying within-and between-animal variation and uncertainty associated with counts of Escherichia coli O157 occurring in naturally infected cattle faeces. J R Soc Interface 6(31):169-177.
32. Matthews L, et al. (2009) Exploiting strain diversity to expose transmission heterogeneities and predict the impact of targeting supershedding. Epidemics 1(4):221-229.
33. Matthews L, et al. (2006) Super-shedding cattle and the transmission dynamics of Escherichia coli O157. Epidemiol Infect 134(1):131-142.
34. Matthews L, et al. (2006) Heterogeneous shedding of Escherichia coli O157 in cattle and its implications for control. Proc Natl Acad Sci USA 103(3):547-552.
35. Xu X, et al. (2012) Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli. PLoS Pathog 8(5):e1002672.
36. Hurd HS, Malladi S (2012) An outcomes model to evaluate risks and benefits of Escherichia coli vaccination in beef cattle. Foodborne Pathog Dis 9(10):952-961.
37. Ogden ID, et al. (2002) Long-term survival of Escherichia coli O157 on pasture following an outbreak associated with sheep at a scout camp. Lett Appl Microbiol 34(2): 100-104.
38. Strachan NJC, Dunn GM, Locking ME, Reid TMS, Ogden ID (2006) Escherichia coli O157: Burger bug or environmental pathogen? Int J Food Microbiol 112(2):129-137.
39. Greig JD, Ravel A (2009) Analysis of foodborne outbreak data reported internationally for source attribution. Int J Food Microbiol 130(2):77-87.
40. Buzby JC, Roberts T (2009) The economics of enteric infections: Human foodborne disease costs. Gastroenterology 136(6):1851-1862.
41. Tariq L, Haagsma J, Havelaar A (2011) Cost of illness and disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. J Food Prot 74(4):545-552.
42. Unnevehr LJ (2006) International Association of Agricultural Economists (IAAE). Available at http://ageconsearch.umn.edu/handle/25733. Accessed October 16, 2012.
43. Richards TJ, Nganje WE, Acharya RN (2009) Public goods, hysteresis, and underinvestment in food safety. J Agric Res Econ 34(3):464-482.
44. Fisman DN, Laupland KB (2009) The sounds of silence: Public goods, externalities, and the value of infectious disease control programs. Can J Infect Dis Med Microbiol 20(2): 39-41.
45. Jensen HH, Roberts T, Unnevehr L, Hamm S (1995) in The economics of reducing health risk from food. Proceedings of NE-165 Conference, ed Caswell JA, Food Policy Marketing Center, Department of Agricultural and Resource Economics, University of Connecticut.
46. Locking ME, et al. (2011) Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis 17(3):524-527.
47. Foster G, et al. (2003) A comparison of two pre-enrichment media prior to immunomagnetic separation for the isolation of E. coli O157 from bovine faeces. J Appl Microbiol 95(1):155-159.
48. Wang G, Clark CG, Rodgers FG (2002) Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. J Clin Microbiol 40(10): 3613-3619.